Below are the Nasdaq 100 companies that are within 20% of the 52-week low. This list is strictly for the purpose of researching whether or not the companies have viable business models. Although theses companies are very risky, they provide significant opportunity to outperform the market in the coming year.
| Symbol | Name | Price | P/E | EPS | Yield | P/B | % from Low |
| CSCO | Cisco Systems, Inc. | $18.85 | 14.26 | $1.32 | 0 | 2.26 | 1.56% |
| AMGN | Amgen Inc. | $52.24 | 10.91 | $4.79 | 0 | 2.04 | 3.94% |
| CEPH | Cephalon, Inc. | $58.63 | 11.13 | $5.27 | 0 | 1.68 | 6.60% |
| TEVA | Teva Pharma. | $51.89 | 14.16 | $3.66 | 1.70% | 2.13 | 10.43% |
| ATVI | Activision Blizzard, Inc | $11.07 | 33.55 | $0.33 | 1.50% | 1.3 | 10.81% |
| CELG | Celgene Corp. | $53.47 | 28.44 | $1.88 | 0 | 4.79 | 11.35% |
| EXPE | Expedia, Inc. | $20.96 | 14.36 | $1.46 | 1.30% | 2.15 | 14.54% |
| MSFT | Microsoft Corp. | $27.06 | 11.55 | $2.34 | 2.40% | 4.72 | 19.05% |
| MICC | Millicom Intl. Cellular | $90.27 | 5.92 | $15.24 | 2.60% | 3.06 | 19.86% |
Watch List Performance Review
In our ongoing review of the Nasdaq 100 Watch List, we have taken the stocks from our list of February 21, 2010 (article here) and have checked their performance one year later. The companies on that list are provided below with the closing price for February 19, 2010 and February 18, 2011.
Four of the companies on our list managed to exceed the Nasdaq 100 while the other four on the list underperformed the index. Stericycle (SRCL) was the biggest winner with a 60.92% gain. Gilead Sciences (GILD) was the biggest loser over the last year with a decline of -19.53%.
| Symbol | Name | 2010 | 2011 | Change |
| APOL | Apollo Group | $56.92 | $45.82 | -19.50% |
| ERTS | Electronic Arts | $16.75 | $19.28 | 15.10% |
| FSLR | First Solar | $116.00 | $168.22 | 45.02% |
| ATVI | Activision | $10.79 | $11.07 | 2.59% |
| PPDI | Pharma Prod. | $21.20 | $27.97 | 31.93% |
| SRCL | Stericycle | $54.30 | $87.38 | 60.92% |
| GENZ | Genzyme | $55.97 | $75.38 | 34.68% |
| GILD | Gilead | $48.84 | $39.30 | -19.53% |
| Average | 18.90% | |||
| NDX | Nasdaq 100 | 1823.32 | 2392.47 | 31.22% |